A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

Braak H, Braak E. Pathology of Alzheimer's disease. In: Calne DB, ed. Neurodegenerative diseases. Philadelphia: W.B. Saunders, 1994:585-613.

Davies P. An update on the neurochemistry of Alzheimer disease. In: Mayeux R, Rosen WG, eds. The dementias. Vol. 38 of Advances in neurology. New York: Raven Press, 1983:75-86.

Harman D. The free radical theory of aging. In: Pryor WA, ed. Free radicals in biology. Vol. 5. New York: Academic Press, 1982:255-75.

Porta EA. Role of oxidative damage in the aging process. In: Chow CK, ed. Cellular antioxidant defense mechanisms. Vol. 3. Boca Raton, Fla.: CRC Press, 1988:1-52.

10.1073/pnas.88.23.10540

10.1038/382120b0

10.1111/j.1600-0404.1983.tb01517.x

10.1056/NEJM199301213280305

10.1097/00002826-199004000-00004

10.1159/000116655

Burke WJ, 1993, J Am Geriatr Soc, 41, 1219, 10.1111/j.1532-5415.1993.tb07306.x

10.1016/0166-2236(85)90010-4

10.1016/0006-8993(90)91386-U

10.1089/neu.1988.5.61

10.1111/j.1471-4159.1985.tb08800.x

10.1016/0006-291X(92)90837-B

Morris JC, 1993, Neurology, 43, 2412, 10.1212/WNL.43.11.2412-a

10.1097/00002093-199601030-00004

10.1192/bjp.114.512.797

Rosen WG, 1984, Am J Psychiatry, 141, 1356, 10.1176/ajp.141.11.1356

10.1016/0022-3956(75)90026-6

Stern Y, 1994, J Gerontol A Biol Sci Med Sci, 49, M216, 10.1093/geronj/49.5.M216

Tariot PN, 1995, Am J Psychiatry, 152, 1349, 10.1176/ajp.152.9.1349

Richards M, 1991, Arch Neurol, 48, 1147, 10.1001/archneur.1991.00530230055021

10.2307/2531341

Holm S, 1979, Scand J Stat, 6, 65

10.1016/S0197-2456(84)80014-8

10.1001/jama.268.18.2523

10.1001/jama.271.13.985

Thal LJ, 1996, Neurology, 47, 705, 10.1212/WNL.47.3.705

Peyser CE, 1995, Am J Psychiatry, 152, 1771, 10.1176/ajp.152.12.1771

10.1080/10408399509527684

Meydani SN, 1995, Am J Clin Nutr, 62, 1462s, 10.1093/ajcn/62.6.1462S

Flagg EW, 1995, J Am Coll Nutr, 14, 419, 10.1080/07315724.1995.10718532